Cvs Health (CVS) Depreciation & Amortization (CF) (2009 - 2026)

Cvs Health (CVS) has 18 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 3.38% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 billion (down 1.0% YoY) and the FY2025 annual result came in at $4.6 billion, changed 0.2% from the prior year.
• Depreciation & Amortization (CF) slipped to $1.1 billion in Q1 2026, from $1.1 billion in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.2 billion in Q2 2025 to a low of $1.0 billion in Q1 2023.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) decreased 7.41% — and 2024, when it gained 13.69%.
• Tracing CVS's Depreciation & Amortization (CF) over 5 years: stood at $1.0 billion in 2022, then climbed by 8.72% to $1.1 billion in 2023, then gained by 1.15% to $1.1 billion in 2024, then changed by 0.0% to $1.1 billion in 2025, then declined by 2.79% to $1.1 billion in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.